No significant difference in 1° outcome or 2° outcomes except AKI (AKIN UO). Of randomised pts without AKI initially (n = 104) EPO patients had higher %plasmaCr↑: EPO 8.5 ± 27(n = 61), Placebo -4.6 ± 18 (n = 47; p = 0.004). The gene discussed is EPO; the disease is acute kidney injury.